Cytek Biosciences Inc Working Capital to Net Assets Ratio
Cytek Biosciences Inc working capital to net assets ratio. Cytek Biosciences Inc (CTKB) has a Working Capital to Net Assets ratio of 91.1% as of March 2026. Working capital of $298.37 Million (current assets of $379.30 Million minus current liabilities of $80.94 Million) is measured against net assets of $327.64 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of Cytek Biosciences Inc to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Cytek Biosciences Inc (2019–2025)
Working capital to net assets ratio of Cytek Biosciences Inc from 2019 to 2025. This chart shows how Cytek Biosciences Inc's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 91.1%, reflecting working capital of $298.37 Million against net assets of $327.64 Million USD. See operational self-sufficiency of Cytek Biosciences Inc to measure how many days the company can operate on defensive assets alone.
Cytek Biosciences Inc Working Capital to Net Assets Ratio by Year (2019–2025)
Cytek Biosciences Inc working capital to net assets ratio by year from 2019 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Cytek Biosciences Inc from 2019 to 2025, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Cytek Biosciences Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 91.9% | $314.19 Million | $341.74 Million | $392.00 Million | $77.80 Million | ▲ +8.9 pp |
| 2024 | 83.1% | $328.78 Million | $395.74 Million | $396.45 Million | $67.66 Million | ▼ -2.4 pp |
| 2023 | 85.4% | $335.83 Million | $393.06 Million | $392.06 Million | $56.23 Million | ▼ -9.7 pp |
| 2022 | 95.2% | $404.98 Million | $425.55 Million | $454.02 Million | $49.04 Million | ▼ -3.1 pp |
| 2021 | 98.3% | $398.55 Million | $405.38 Million | $431.73 Million | $33.18 Million | ▲ +1234.4 pp |
| 2020 | -1136.0% | $182.09 Million | $-16.03 Million | $208.62 Million | $26.54 Million | ▼ -1024.0 pp |
| 2019 | -112.1% | $46.73 Million | $-41.70 Million | $67.77 Million | $21.04 Million | — |